Today, 303 LEAD Coalition member organizations and allies sent a joint public comment letter to the U.S. Food and Drug Administration (FDA) regarding its draft guidance for the study of sex differences in the clinical evaluation of medical products (Docket No. FDA-2024-D-4245). The letter, co-led by the Society for Women’s Health Research, supports the draft […]

Read the March 31st LEAD Coalition Newsletter below.

Read the February 26th LEAD Coalition Newsletter below.

Read the January 29th LEAD Coalition Newsletter below.

Read the December 31st LEAD Coalition Newsletter below.

Read the November 25th LEAD Coalition Newsletter below.

Read the October 30th LEAD Coalition Newsletter below.

Read the September 30th LEAD Coalition Newsletter below.

Read the August 28th LEAD Coalition Newsletter below.

The LEAD Coalition has submitted a letter providing input on House Energy and Commerce Committee Chair Cathy McMorris Rodgers’ “Reforming the National Institutes of Health Framework for Discussion.” The LEAD Coalition letter encourages a congressional process that ensures Alzheimer’s disease and related disorders research continues to be addressed collaboratively across NIH with a life-course, person-centered […]